跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FARAZID - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
FARAZID
Approved
STANDARD
FARAZID
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cb1d131ae06aaf3d
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
cb1d131ae06aaf3d
Drug Approval Philippines Name
FARAZID
Product Name
FARAZID
Registration Number
DRP-1252-05
Brand Name
FARAZID
Generic Name
PARACETAMOL + PHENYLEPHRINE HYDROCHLORIDE + DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form
Capsule
Dosage Strength
325 mg/25 mg/10 mg
Manufacturer
J.M. Tolmann Laboratories, Inc.
Distributor
APT Drugs Trading Rm.
Issuance Date
29 June 2021
Expiry Date
20 August 2028
Pharmacologic Category
ANALGESIC / ANTIPYRETIC / NASAL DECONGESTANT / ANTITUSSIVE
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cb1d131ae06aaf3d
Type
Standard
Back to Philippines FDA Approvals